Network pharmacology-based investigation of salidroside targets and mechanisms in the treatment of rectal cancer
Integrate Medicine · 31.10.2025
DOI: 10.61958/impk3613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrate Medicine, online erschienen am 31.10.2025. Verfasst von Fan-Wei Zhou. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Objective
Rectal cancer is among the most common malignancies; however, no effective pharmacological treatments are currently available. This study aimed to investigate the association between salidroside, rectal cancer, and rectal cancer–related protein targets, thereby providing potential insights for the development of salidroside-based targeted therapy.
Methods
Targets related to salidroside and rectal cancer were retrieved from the High-throughput Experiment- and Reference-guided database of Traditional Chinese Medicine (HERB), the Human Gene Database (GeneCards), and the Encyclopedia of Traditional Chinese Medicine (ETCM). Venn analysis was applied to identify common targets, and a protein–protein interaction (PPI) network was constructed using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database. Cytoscape software was then employed to identify hub genes, which were subsequently subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Finally, a protein pathway network was established.
Results
Venn analysis identified 44 overlapping targets. A PPI network was constructed, and ten hub protein targets were identified through network pharmacology, including BCL2-like 1 (BCL2L1), Interleukin 6 (IL6), Tumor Necrosis Factor (TNF), Mechanistic Target of Rapamycin (MTOR), Nuclear Factor, Erythroid 2 Like 2 (NFE2L2), Hypoxia-Inducible Factor 1 Subunit Alpha (HIF1A), Caspase 3 (CASP3), Caspase 8 (CASP8), B-cell Lymphoma 2 (BCL2), and AKT Serine/Threonine Kinase 1 (AKT1). GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses further elucidated the biological processes and signaling pathways involved.
Conclusions
This study demonstrates the potential therapeutic effects of salidroside against rectal cancer at the molecular level and provides new research directions for the development of salidroside-based therapies.
Zitieren
APA
Zhou, F. (2025). Network pharmacology-based investigation of salidroside targets and mechanisms in the treatment of rectal cancer. Integrate Medicine. https://doi.org/10.61958/impk3613
Vancouver
Zhou F. Network pharmacology-based investigation of salidroside targets and mechanisms in the treatment of rectal cancer. Integrate Medicine. 2025. doi:10.61958/impk3613
BibTeX
@article{Zhou2025,
author = {Zhou, Fan-Wei},
title = {Network pharmacology-based investigation of salidroside targets and mechanisms in the treatment of rectal cancer},
journal = {Integrate Medicine},
year = {2025},
doi = {10.61958/impk3613}
}
EUVIMED